The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association
Open accessAbstract
In 2010, the American Heart Association defined a novel construct of cardiovascular health to promote a paradigm shift from a focus solely on disease treatment to one inclusive of positive health promotion and preservation across the life course in populations and individuals. Extensive subsequent evidence has provided insights into strengths and limitations of the original approach to defining and quantifying cardiovascular health. In response, the American Heart Association convened a writing group to recommend enhancements and updates. The definition and quantification of each of the original metrics (Life’s Simple 7) were evaluated for responsiveness to interindividual variation and intraindividual change. New metrics were considered, and the age spectrum was expanded to include the entire life course. The foundational contexts of social determinants of health and psychological health were addressed as crucial factors in optimizing and preserving cardiovascular health. This presidential advisory introduces an enhanced approach to assessing cardiovascular health: Life’s Essential 8. The components of Life’s Essential 8 include diet (updated), physical activity, nicotine exposure (updated), sleep health (new), body mass index, blood lipids (updated), blood glucose (updated), and blood pressure. Each metric has a new scoring algorithm ranging from 0 to 100 points, allowing generation of a new composite cardiovascular health score (the unweighted average of all components) that also varies from 0 to 100 points. Methods for implementing cardiovascular health assessment and longitudinal monitoring are discussed, as are potential data sources and tools to promote widespread adoption in policy, public health, clinical, institutional, and community settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Preventing the development of hypertension reduces risk more than treating existing hypertension.36,37”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Regular assessments of lipids, glycemia, and kidney function (eg, eGFR) are recommended with increasing frequency for higher CKM stages, as the risk for progressive metabolic and kidney disease increases along the CKM spectrum.13,18–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ultimately, adverse SDOH have downstream consequences on cardiovascular and all-cause mortality11,14 and contribute to disparities in CVD mortality.21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Because the exact relative importance of each CVD risk factor was unclear in this specific population, we used the unweighted average of the four CVD risk factors, which is also common for a composite CVD risk score generation.14”
From Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These four traditional CVD risk factors are often included in routine composite CVD risk algorithms to predict future CVD in clinical practice.10,11,14,22”
From Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial (2024) · cites this paper as [14]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“One small, randomized crossover trial among 44 adults with diabetes and food insecurity found that a medically tailored meal delivery program improved dietary quality and food insecurity and reduced hypoglycemia.21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“MBS, the most potent weight loss therapy, has become safer, with less invasive surgical options over time.20,21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Greater amounts of intentional weight loss are associated with more substantial improvement in CKM risk factors,20 with some possible reductions in CVD risk with ≥10% weight loss.21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Time-restricted eating, the most popular form of which is intermittent fasting, has demonstrated some weight loss efficacy,33,34 but studies indicate it is no more effective than a calorie-limited approach in promoting weight loss or improving cardiovascular risk.35,36”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“CKM risk factor remission is superior with RYGB bypass compared with LSG.20,21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Counseling on dietary or combined dietary and exercise modifications effectively facilitates weight loss in postpartum women with GDM.6,19–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“population-based analyses demonstrating that the overwhelming majority of individuals with CKD and T2D or albuminuria have a 10-year PREVENT-CVD score ≥7.5%.21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Clinical trials have indicated a lack of heterogeneity in the effects of each class of these cardioprotective glucose-lowering therapies between those who were and were not taking the other agent.17–19,21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Incidentally identified moderate-to-severe coronary calcifications on a nongated chest computed tomography scan typically correlates with CAC ≥100, carries similar prognostic value, and can also identify patients with CKM syndrome most likely to benefit from preventive therapies.21–24”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, a more recent meta-analysis that included 10 GLP-1 RA trials estimated a 13% reduction in HF hospitalization (HR, 0.87 [95% CI, 0.80–0.94]).36”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“CVD risk reduction was observed with semaglutide prior to clinically significant weight loss, and similar CVD event reductions were observed regardless of the magnitude of weight achieved,21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“indicating some cardiovascular benefits that are weight-independent”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“GLP-1–based therapy often causes significant weight loss and improvements in CKM risk profiles and MASLD, while SGLT2i has a marked impact on CKD.19–30”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Both SGLT2i and GLP-1–based therapy improve kidney outcomes,49–51 with GLP-1–based therapy additionally promoting significant weight reduction and glycemic control (especially semaglutide and tirzepatide)19–25 and reducing liver fibrosis in MASH”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In patients with T2D and ASCVD, SGLT2i and GLP-1–based therapy significantly reduces the risk of MACE and cardiovascular mortality, promotes weight loss,34 and reduces progression of kidney disease”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Several trials corroborate the safety and efficacy of exercise training for HFpEF, but these did not exclusively recruit patients with obesity.21–23”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While there is growing evidence for GLP-1 benefit in HFpEF, there is less clarity regarding efficacy and safety in HFrEF, based on somewhat increased risk for adverse outcomes among patients taking GLP-1 RA in small HFrEF trials.19–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Two high-quality simulation model–based cost-effectiveness analyses projected that adding SGLT2i therapy to prior GDMT in adults with symptomatic HFrEF was cost-effective from a US health care sector perspective and a lifetime analytic horizon,35,36 with an incremental cost-effectiveness ratio between $68 000 and $84 000 per QALY gained (assuming an annual drug cost of $4192 to $5684, which is con”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In adults with CKM syndrome stage 4 syndrome with CKD and symptomatic HF with LVEF ≤40%, addition of an SGLT2i prior to GDMT at 2025 US prices is projected to be cost-effective compared with prior GDMT.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, neither study specifically examined the subgroup of individuals with CKD.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In probabilistic sensitivity analyses, the incremental cost-effectiveness ratio was <$120 000 per QALY gained in >95% of the simulations in 1 analysis,35 and approximately 70% of the simulations in the other.36”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Among these 4 medication classes (6 classes if the patient also self-identifies as Black race), 2 are kidney-protective; namely, 1) RASi, with ARNI having superior HF benefits over ACEi/ARB; and 2) SGLT2i.13,21–25”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“RASi, with ARNI having superior HF benefits over ACEi/ARB; and 2) SGLT2i.13,21–25”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Assessment of fibrosis risk starts with the FIB-4 index, with further sequential assessments as needed to rule out (or rule in) clinically significant fibrosis (≥ stage 2).19–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Moreover, it is an independent risk factor for CVD morbidity and mortality.36”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“DOACs offer advantages over VKAs: rapid onset, predictable effect, wider therapeutic window, no routine monitoring, and fewer food/drug interactions.21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In stage G3 CKD (eGFR, 30–59 mL/min/1.73 m2), subgroup analyses suggest DOACs are noninferior to VKA for recurrent VTE or major bleeding.35–38”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“DOAC kidney clearance varies (dabigatran 80%, edoxaban 50%, rivaroxaban 35%, apixaban 27%).21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The CHAP (Chronic Hypertension and Pregnancy) trial demonstrated that optimizing BP control during pregnancy to target <140/90 mm Hg was associated with lower risk of adverse maternal and fetal outcomes.36”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Multiple RCTs of CKM therapies included albuminuria as an eligibility criterion, with absolute risk reductions for cardiovascular and kidney outcomes commonly greater for those with more baseline albuminuria.12,15,33–38”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Self-citationHeart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Self-citationHeart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Self-citationLloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750
Self-citationSleep Health: Can We Define It? Does It Matter?
Buysse, D. J. (2014) · SLEEP · doi:10.5665/sleep.3298 · Cited by 2,768
National Sleep Foundation’s updated sleep duration recommendations: final report
Hirshkowitz, M., Whiton, K., Albert, S. M., Alessi, C., Bruni, O., DonCarlos, L., Hazen, N., Herman, J., Adams Hillard, P. J., Katz, E. S., et al. (2015) · Sleep Health · doi:10.1016/j.sleh.2015.10.004 · Cited by 2,348
Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies
Cappuccio, F. P., D'Elia, L., Strazzullo, P., & Miller, M. A. (2010) · Sleep · doi:10.1093/sleep/33.5.585 · Cited by 2,224
Slavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206
Research works printed but not linked: 3
- Allen, NB, Hwang, S-J, Cupples, LA, Levy, D, Fox, C, O’Donnell, C, Lloyd-Jones, D. The heritability of ideal cardiovascular health: the Framingham Heart Study. Circulation. 2010;122:A17245–A17245. Abstract 17245.
- Health, United States, 2011: With Special Feature on Socioeconomic Status and Health. National Center for Health Statistics; 2012.
- Gao, S. Diet and Exercise: Behavioral Management of Hypertension and Diabetes [dissertation]. Seattle: University of Washington, 2006.
Cited by
Sorted by citations
Items 801–900 of 1,001
Xue, E., Zhao, J., Chen, B., Ye, J., Wu, J., Shao, J., Li, X., & Ye, Z. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156596 · Cited by 7
Acierno, C., Orio, M., Schiavo, L., Saracino, A., & Stabile, E. (2026) · Biomedicines · doi:10.3390/biomedicines14040790 · Cited by 7
Qureshi, F., Guimond, A., Tsao, E., Delaney, S., Boehm, J. K., & Kubzansky, L. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.026173 · Cited by 8
Cardiovascular Health in People with Psoriasis: A Population-Based Study in the United States
Wang, S., Shin, D. B., Bhutani, T., Garshick, M. S., & Gelfand, J. M. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.04.006 · Cited by 7
Dessureault, L., Roy, G., Couture, P., Gangloff, A., Guasch‐Ferré, M., Përusse, L., Tremblay, A., & Drouin‐Chartier, J. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.06.014 · Cited by 7
Sueño y riesgo cardiometabólico. Revisión narrativa
Rodulfo, J. I. A., Aure, G., & Viñoles, F. C. (2023) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2023.08.001 · Cited by 8
Eveningness is associated with coronary artery calcification in a middle-aged Swedish population
Frisk, M. K., Fagman, E., Arvidsson, D., Ekblom, Ö. B., Börjesson, M., Bergström, G. M. L., & Zou, D. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.11.004 · Cited by 7
Suglia, S. F., Knox, N., April-Sanders, A., Aguayo, L., Lopez‐Cepero, A. A., COHALL, A. T., Wang, S., Wall, M. M., CANINO, G. J., Bird, H., et al. (2023) · Annals of Epidemiology · doi:10.1016/j.annepidem.2023.11.007 · Cited by 7
Digital Health for Oncological Care
Cohen, A. B., & Schwamm, L. H. (2024) · The Cancer Journal · doi:10.1097/ppo.0000000000000693 · Cited by 7
Sociodemographic Associations with Blood Pressure in 10–14-Year-Old Adolescents
Nagata, J. M., Shim, J. E., Balasubramanian, P., Talebloo, J., Al-shoaibi, A. A. A., Shao, I. Y., Ganson, K., Testa, A. M., Dooley, E. E., Gooding, H., et al. (2024) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2023.12.015 · Cited by 6
Osibogun, O. I., Ogunmoroti, O., Turkson‐Ocran, R., Okunrintemi, V., Kershaw, K. N., Allen, N. B., & Michos, E. D. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100640 · Cited by 7
Self-citationTrends in Income Inequities in Cardiovascular Health Among US Adults, 1988–2018
Brownell, N. K., Ziaeian, B., JACKSON, N. J., & Richards, A. K. (2024) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.123.010111 · Cited by 7
Lu, S.-Y., & Gao, G.-N. (2024) · International Dental Journal · doi:10.1016/j.identj.2024.03.011 · Cited by 7
Keiser, T., Katz, S. E., Robson, S. M., Greaney, J. L., Healy, S., Malone, S. K., Farrahi, V., & Patterson, F. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003732 · Cited by 7
Higueras‐Fresnillo, S., Herráiz-Adillo, Á., Ahlqvist, V. H., Öberg, R., Lenander, C., Wennberg, P., Wångdahl, J. M., Berglind, D., Daka, B., Östgren, C. J., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-18924-w · Cited by 7
Arabidze, G. G., & Мамедов, М. Н. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-5772 · Cited by 7
The effects of adverse and positive experiences on cardiovascular health in Australian children
Guo, S., Wijesuriya, R., O’Connor, M., Moreno‐Betancur, M., Goldfeld, S. R., Burgner, D. P., Liu, R., & Priest, N. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132262 · Cited by 7
Cardio-reno-Metabolic health: discussing the recommendations of the American Heart Association
Izmaylova, M. Y., Demidova, T. Y., & Владимировна, В. В. (2024) · FOCUS Endocrinology · doi:10.62751/2713-0177-2024-5-2-16 · Cited by 7
Yan, B., Jin, Y., Mao, S., & Yin, Y. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03947-3 · Cited by 7
Ramos, S. R., Reynolds, H. R., Johnson, C., Melkus, G. D., Kershaw, T., Thayer, J. F., & Vorderstrasse, A. A. (2024) · Journal of Medical Internet Research · doi:10.2196/57351 · Cited by 7
Yaqin, W., Deng, S., Ting, Y., Zhu, X., Yuling, D., Liu, L., & Changfa, W. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00821-z · Cited by 7
Pérez, C. M., Kiefe, C., Person, S. D., Tucker, K. L., Torres, P., Sandoval, E., Boneu, C., Ramírez, Z., Mattei, J., Rodriguez-Orengo, J. F., et al. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae163 · Cited by 5
Aqua, J. K., Barnum, O., & Johnson, D. A. (2024) · SLEEP · doi:10.1093/sleep/zsae142 · Cited by 7
Advances in predicting cardiovascular risk: Applying the PREVENT equations
Garba, D. L., Razavi, A. C., Blumenthal, R. S., Stone, N. J., Polonsky, T. S., Khan, S. S., & Barouch, L. A. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100705 · Cited by 7
Xu, W., Feng, Y., Abdullah, G., Li, L., Fang, P., Tang, S., Yang, H., Kong, D., Huang, H., Wang, Y., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1376463 · Cited by 7
Guo, D.-C., Chen, Z.-T., Wang, X., Gao, J., Gao, Q., Huang, Z.-G., Chen, Y., Liu, P., Wang, J., & Zhang, H. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.07.007 · Cited by 7
Perng, W., Galai, N., Zhao, Q., Litonjua, A. A., Geiger, S. D., Sauder, K. A., O’Shea, T. M., Hivert, M., Oken, E., Dabelea, D., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.036279 · Cited by 7
Chen, M., Chen, Y., & Li, C. (2024) · Quality of Life Research · doi:10.1007/s11136-024-03769-y · Cited by 7
Current topic of vascular function in hypertension in 2023–2024
Maruhashi, T., & Higashi, Y. (2024) · Hypertension Research · doi:10.1038/s41440-024-01885-3 · Cited by 7
CARDIA sleep ancillary study: study design and methods
Knutson, K. L., Reid, K. J., Karanth, S., Kim, N., Abbott, S. M., Alexandria, S. J., Harrington, K. A., Thomas, S. J., Lewis, C. E., Schreiner, P. J., et al. (2024) · SLEEP Advances · doi:10.1093/sleepadvances/zpae071 · Cited by 7
Brazilian Guideline on Menopausal Cardiovascular Health – 2024
de Oliveira, G. M. M., de Almeida, M. C. C., Artucio, C., Espíndola, L. N., Rivera, M. A. M., Filho, A. L. D. S., Marques-Santos, C., Fernandes, C. E., Albuquerque, C. J. D. M., Freire, C. M. V., et al. (2024) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2024rbgo100 · Cited by 7
Anaya, G., Gabriel, K. P., St‐Onge, M., Horn, L. V., Alfini, A. J., Badon, S. E., Boushey, C. J., Brown, A. G. M., Depner, C. M., Diaz, K. M., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.035818 · Cited by 7
Self-citationAssociations between AHA's Life's Essential 8 and cognition in midlife and older adults
Master, L., Shen, Y., Allan, A. C., Beydoun, M. A., Zonderman, A. B., Evans, M. K., Buxton, O. M., & Gamaldo, A. A. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14294 · Cited by 7
The role of social determinants in alcohol consumption and cardiovascular health: The pathways study
Liu, M., Pan, Y., Wang, Z., Wang, J., Shi, Y., & Chu, J. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.10.021 · Cited by 7
Tincher, I. M., Rojas, D. A., Yuan, M., Abukhadra, S. L., DeForge, C. E., Thomas, S. J., Flanary, K., Shimbo, D., Makarem, N., Chang, B., et al. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.10.007 · Cited by 7
Lalika, M., Jenkins, S. M., Hayes, S. N., Jones, C., Burke, L. E., Cooper, L. A., Patten, C. A., & Brewer, L. C. (2024) · Digital Health · doi:10.1177/20552076241295305 · Cited by 7
Self-citationZeng, X., Chen, R., Shi, D., Zhang, X., Su, T., Wang, Y., Hu, Y., He, M., Yu, H., & Shang, X. (2024) · Aging Cell · doi:10.1111/acel.14435 · Cited by 7
Life's Essential 8 and kidney stones in US adults: mediating roles of HDL and insulin resistance
Yang, Q., Hanyuan, L. I. N., Zhang, X., Haoxian, T. A. N. G., Huang, J., Luo, N., & Qingtao, Y. A. N. G. (2025) · Minerva Urology and Nephrology · doi:10.23736/s2724-6051.24.05774-4 · Cited by 7
Life’s Essential 8 and cardiovascular disease in women with a history of adverse pregnancy outcomes
Chen, H., Li, R., Liu, S., Zhao, S., Guo, T., Tian, S., Zhong, J., Tang, Z.-J., Ge, Z., Xia, J., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf021 · Cited by 7
Social epidemiology of cardiometabolic risk factors in early adolescents
Nagata, J. M., Helmer, C. K., Wong, J. H., Lee, S., Domingue, S. K., Low, P., Al-Shoaibi, A. A. A., Shim, J. E., Ganson, K. T., Testa, A. M., et al. (2025) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2025.200382 · Cited by 7
Duan, Y., Xu, C., Wang, W., Wang, X., Xu, N., Zhong, J., Gong, W., Zheng, W., Wu, Y., Myers, A., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-03969-4 · Cited by 7
Food Insecurity and Its Cardiovascular Implications in Underresourced Communities
Porras‐Pérez, E., Romero‐Cabrera, J. L., Cáceres, A. D., Jiménez, A. S., Arenas‐Montes, J., Peña‐Orihuela, P. J., de-Castro-Burón, I., García‐Ríos, A., Torres-Peña, J. D., Malagón, M. M., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.037457 · Cited by 7
Wu, X., Li, X., & Liu, H. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1519954 · Cited by 7
Razavi, A. C., Troy, A. L., Patel, J., Mehta, L. S., Spitz, J. A., Lloyd‐Jones, D. M., Whelton, S. P., Johansen, M. C., & Blumenthal, R. S. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101724 · Cited by 8
Self-citationHigh Life’s Essential 8 score is associated with lower aortic valve calcification
Gui, M., Chen, S., Yang, Q., Wang, J., Gao, Y., Han, Y., Deng, J., Zhao, M., Liu, P., Zhao, N., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf285 · Cited by 7
Sleep quality, sleep apnea, and metabolic health in children treated with adenotonsillectomy
Magnúsdóttir, S., Witmans, M., & Hilmisson, H. (2022) · Sleep And Breathing · doi:10.1007/s11325-022-02747-3 · Cited by 7
Brutto, Ó. H. D., Mera, R. M., Rumbea, D. A., Recalde, B. Y., & Sedler, M. J. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.12.044 · Cited by 7
Proteomic Mediators of Overall Cardiovascular Health on All-Cause Mortality
Tanaka, T., Talegawkar, S. A., Jin, Y., Candia, J., Fantoni, G., Bandinelli, S., & Ferrucci, L. (2023) · Nutrients · doi:10.3390/nu15030781 · Cited by 7
Huang, L., He, M., Shen, J., Gong, Y., Chen, H., Xu, X., Zong, G., Zheng, Y., Jiang, C. Q., Wang, B., et al. (2023) · Health care science · doi:10.1002/hcs2.59 · Cited by 7
Impact of bimonthly repeated total sleep deprivation and recovery sleep on cardiovascular indices
Pasetes, L. N., Garcia, K., & Goel, N. (2023) · Physiological Reports · doi:10.14814/phy2.15841 · Cited by 7
Salty Subjects: Unpacking Racial Differences in Salt-Sensitive Hypertension
Jeong, S., Hunter, S. D., Cook, M. D., Grosicki, G. J., & Robinson, A. T. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01275-z · Cited by 7
Besel, J. M., Insel, K. C., & Williams, G. C. (2023) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000001052 · Cited by 9
Castillo, M. F., Salgado-Canales, D., Arrese, M. A., Francisco Barrera, M., & Mikhailidis, D. P. (2024) · Current Vascular Pharmacology · doi:10.2174/0115701611285401240110074530 · Cited by 7
Covert Cerebral Small Vessel Disease: Ready for Clinical Prime Time
Hannawi, Y., Vaishnav, A. G., Coskun, E. P., Gangadhara, S., & Romero, J. R. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029891 · Cited by 7
Ignoring Mental Well-Being Is Costing Lives
Blumenthal, R. S., Mehta, A., & Chandiramani, R. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101113 · Cited by 7
Solanki, A., Kamrava, M. R., Posadas, E. M., Freedland, S. J., Ballas, L., Sandler, H. M., Merz, C. N. B., Atkins, K. M., & Nikolova, A. (2024) · Cancer · doi:10.1002/cncr.35285 · Cited by 6
Pérez, C. M., Lopez‐Cepero, A. A., Almodóvar‐Rivera, I., Kiefe, C. I., Tucker, K. L., Person, S. D., Mattei, J., Rodríguez‐Orengo, J. F., & Rosal, M. C. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.035052 · Cited by 6
Complex interactions and composite burden of risk factors in vascular cognitive impairment
Ji, L., & Zhang, J. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123367 · Cited by 6
Dai, L., Jiang, C., Cui, Q., Huang, L., Chen, S., Zhang, Y., Luo, X., Zhang, P., Li, J., & Zhang, Y. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100020 · Cited by 6
Brief Mindfulness-Based Cognitive Therapy in Women With Myocardial Infarction
Spruill, T. M., Park, C., Kalinowski, J., Arabadjian, M. E., Xia, Y., Shallcross, A. J., Visvanathan, P. D., Smilowitz, N. R., Hausvater, A., Bangalore, S., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2024.101530 · Cited by 6
Gibbs, B. B., Modlin, S. E., Merz, C. N. B., Haas, D. M., Khan, S. S., Lane, A. D., McNeil, R. B., Varagić, J., Huber, K., Vasquez-Huot, L. M., et al. (2025) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003660 · Cited by 6
Digital Transformation in Cardiology ― Mobile Health ―
Yada, H., & Soejima, K. (2025) · Circulation Journal · doi:10.1253/circj.cj-24-0654 · Cited by 6
Zhang, Z., Wang, C., Zhao, L. Y., Wang, Z., Zhou, X., Yang, W., & Meng, X. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16293 · Cited by 7
Sapkota, S., Maillard, P., Stickel, A. M., Tarraf, W., González, K. A., Ivanović, V., Paredes, A. M., Cai, J., Isasi, C. R., Lipton, R. B., et al. (2025) · Stroke · doi:10.1161/strokeaha.124.049904 · Cited by 6
He, P., Li, H., Liu, M., Ye, Z., Zhou, C., Zhang, Y., Yang, S., Zhang, Y., & Qin, X. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003491 · Cited by 6
Association of Sleep Duration With Incident Carotid Plaque: A Prospective Cohort Study
Chen, M., Ma, X., Xue, Y., Wang, X., Zhao, Y., Yan, P., Liu, X. L., Du, Y., Qiu, C., & Sun, Q. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.039215 · Cited by 7
Racial and ethnic variation in socioeconomic differentials in young adult cardiovascular health
Goldman, N., Allen, N. B., Pratt, B., Ning, H., Schneper, L. M., Lloyd‐Jones, D. M., & Notterman, D. A. (2025) · American Journal of Epidemiology · doi:10.1093/aje/kwaf100 · Cited by 6
Self-citationBeydoun, M. A., Georgescu, M. F., Weiss, J., Hooten, N. N., Beydoun, H. A., Tsai, J., Vieytes, C. A. M., Evans, M. K., & Zonderman, A. B. (2025) · Social Science & Medicine · doi:10.1016/j.socscimed.2025.118137 · Cited by 6
Synergistic effects of cardiovascular health and social isolation on adverse pregnancy outcomes
Ohseto, H., Ishikuro, M., Chen, G., Takahashi, I., Shinoda, G., Noda, A., Murakami, K., Orui, M., Iwama, N., Kikuya, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-03652-x · Cited by 6
Zhao, L., Zhao, C., Wang, Z., Chen, Z., Zheng, H., Ai, S., Tao, J., Li, D., Sun, W., & Wang, Y. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2508295 · Cited by 6
Bai, H., Qiu, C., Fan, M., Zhong, Y., Yin, X., Zhang, T., Chen, H. H., Yang, X., Zhang, Y., Lin, S., et al. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00957-6 · Cited by 6
A Critical Evaluation of Social Determinants of Health in Total Joint Arthroplasty
Dubin, J. A., Bains, S. S., Katanbaf, R. M., Swartz, G. N., Misch, M., Mont, M. A., & Delanois, R. E. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.06.067 · Cited by 6
Gu, X., Li, Q., & Wang, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1586828 · Cited by 6
Sleep and Cardiovascular Health: An Introduction to the Series
Redline, S. S. (2025) · Circulation Research · doi:10.1161/circresaha.125.327119 · Cited by 6
Metlock, F., Rayani, A., Stanislas, K. A., Vaidya, D. M., Kwapong, Y. A., Hladek, M. D., Ouyang, P., Hall, J. L., Sharma, G. V., & Commodore-Mensah, Y. Y. (2025) · Health Literacy and Communication Open · doi:10.1080/28355245.2025.2553042 · Cited by 6
Self-citationUnderstanding and managing disordered sleep in people with HIV
Sukumaran, L., Scheuermaier, K. D., Sabin, C. A., Chandiwana, N. C., Gómez-Olivé, F. X., von Schantz, M., Rae, D. E., & Winston, A. (2025) · The Lancet HIV · doi:10.1016/s2352-3018(25)00221-8 · Cited by 6
Methods for Assessment of Sleep and Circadian Rhythms in Cardiovascular Research
Williams, R., Gloston, G. F., Ward, K. C., Jain, S., Hays, K., Ensor, A. E., Patel, S. S., Patel, N., Hogue, M., Thomas, S. J., et al. (2025) · Current Hypertension Reports · doi:10.1007/s11906-025-01345-4 · Cited by 6
Wei, J., Xu, Y., & Liu, Y. (2025) · Maturitas · doi:10.1016/j.maturitas.2025.108753 · Cited by 6
Lavretsky, H., Khalsa, S. S., Oughli, H. A., Ibáñez, A. M., Cruzat, J. C., Edwards, E., NEWHOUSE, P. A., Bassetti, C. L., Bègue, I., Winkler, A. S., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02332-2 · Cited by 6
Self-citationZhou, X.-J., Chen, J.-L., Hu, C.-F., Li, Z.-K., Zheng, H.-B., Ding, T.-N., Chen, Y., Zhu, Y., Li, J.-N., Fu, Q., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1834916 · Cited by 6
Candelaria, D., Redfern, J., Zecchin, R. P., Brown, R., Freene, N., Fukumori, S., Gallagher, R. D., Gauci, S., Goodman, A., Hicks, D., et al. (2026) · Heart Lung and Circulation · doi:10.1016/j.hlc.2026.05.008 · Cited by 8
Wake up! It's time to recognize the importance of sleep in metabolic health
Zuraikat, F. M., Jelić, S., & St‐Onge, M. (2023) · Obesity · doi:10.1002/oby.23776 · Cited by 6
Cagna, D. R., Donovan, T. E., McKee, J. R., Eichmiller, F. C., Metz, J. E., Marzola, R., Murphy, K. G., & Troeltzsch, M. (2023) · Journal of Prosthetic Dentistry · doi:10.1016/j.prosdent.2023.06.001 · Cited by 6
Exploring Nursing Strategies to Engage Community in Cardiovascular Care
Scott, J., Burrison, S., Barron, M., Logan, A., & Magwood, G. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01949-9 · Cited by 6
Sleep Variability, Eating Timing Variability, and Carotid Intima‐Media Thickness in Early Adulthood
Hoopes, E. K., Witman, M. A., D’Agata, M. N., Brewer, B. C., Edwards, D. G., Robson, S. M., Malone, S. K., Keiser, T., & Patterson, F. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029662 · Cited by 6
“What if that’s your last sleep?” A qualitative exploration of the trauma of incarceration and sleep
Elumn, J. E., Li, P., Lytell, M. S., García, M., Wang, E. A., & Yaggi, H. K. (2023) · SLEEP Advances · doi:10.1093/sleepadvances/zpad055 · Cited by 6
Sleep and 24-H Activity Rhythms and the Risk of Stroke: A Prospective Cohort Study
Hoepel, S. J. W., Berghout, B. P., Luik, A. I., & Ikram, M. K. (2024) · Neuroepidemiology · doi:10.1159/000536526 · Cited by 6
The emerging adulthood gap in diabetes prevention research
Arons, A., & Seligman, H. K. (2024) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2024.100699 · Cited by 6
Zhang, D.-W., Zhu, Y., Zhou, S.-J., Chen, X., Li, H., Liu, W., Wu, Z., Chen, Q., & Cao, H. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06529-5 · Cited by 6
Gonzales, J. U., & Dellinger, J. R. (2024) · Nature and Science of Sleep · doi:10.2147/nss.s460212 · Cited by 6
Yang, Q., Chang, A., Tong, X., Jackson, S. L., & Merritt, R. K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302593 · Cited by 6
Gao, S., Su, S., Zhang, E., Liu, J., Xie, S., Zhang, Y., Cui, Y. J., Wang, X., Huang, K., Hu, M., et al. (2024) · Public Health · doi:10.1016/j.puhe.2024.04.028 · Cited by 6
Gutiérrez, M., Márquez, C., Lera, L., Peirano, P. D., Salech, F., & Cecilia Albala, B. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14060578 · Cited by 6
Wang, Q. J., Schmidt, A. F., LENNON, L. T., Papacosta, O., Whincup, P. H., & Wannamethee, S. G. (2024) · Communications Medicine · doi:10.1038/s43856-024-00534-7 · Cited by 6
Garba, D. L., Jacobsen, A. P., Blumenthal, R. S., Martinez, M. W., Ndumele, C. E., Coslick, A. M., & Barouch, L. A. (2024) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2024.100413 · Cited by 6
Association of Life’s Essential 8 with depression among adults: A cross-sectional study of NHANES
Bai, Y., & Guo, S. (2024) · Journal of Investigative Medicine · doi:10.1177/10815589241261286 · Cited by 6
Jing, G., Qian, W., Zou, J., Zhang, Y., Shi, H., & Gao, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-66029-6 · Cited by 6
Özay, C., Aksoyalp, Z. Ş., & Erdoğan, B. R. (2024) · Studies in natural products chemistry · doi:10.1016/b978-0-443-15756-1.00010-0 · Cited by 6
Briones‐Valdivieso, C., Salerno, P. R. V. D. O., Navarrete‐Muñoz, E. M., Valera‐Gran, D., López‐Bueno, R., Al-Kindi, S. G., Deo, S. V. S., & Petermann-Rocha, F. E. (2024) · Public Health · doi:10.1016/j.puhe.2024.06.039 · Cited by 7
Liu, W., Wang, J., Wang, M., Hou, H., Ding, X., Wang, M., & Liu, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36954 · Cited by 6
Metadata
- Authors
- Lloyd-Jones, D. M., Allen, N. B., Anderson, C. A. M., Black, T., Brewer, L. C., Foraker, R. E., Grandner, M. A., Lavretsky, H., Perak, A. M., Sharma, G., Rosamond, W., & on behalf of the American Heart Association
- ORCID
- Venue
- Circulation
- Published
- 2022-08-02
- Volume
- 146
- Issue
- 5
- Pages
- e18-e43
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC10503546
- OpenAlex
- W4283695295
- Semantic Scholar
- 066c19a643fada4d5e4a9c9a68ac02fb8ca11d10
- Cited by
- 2,785
- References
- 226
- Citations by year
- 2026: 650 · 2025: 916 · 2024: 731 · 2023: 432 · 2022: 54
- FWCI
- 108.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- American Heart Association
- Centers for Disease Control and Prevention
- National Heart, Lung, and Blood Institute (K23HL145101)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK092950)
- National Institute for Occupational Safety and Health
- National Institute on Minority Health and Health Disparities (R21MD013490, L60 MD012087)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- cardiovascular health, Life's Essential 8, Life's Simple 7, cardiovascular health score, cardiovascular health assessment, diet, physical activity, nicotine exposure, sleep health, body mass index, serum lipids, blood glucose, blood pressure, social determinants of health, mental health, life course, interindividual variability, long-term monitoring
- MeSH terms
- American Heart Association, Blood Pressure, Cardiovascular Diseases, Heart, Humans, Risk Factors, United States, Exercise
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
